Researchers at the University of Oxford are developing OvarianVax, a vaccine designed to teach the immune system to recognize and attack early-stage ovarian cancer. Funded by Cancer Research UK, the vaccine could potentially be available on the NHS, aiming to eliminate the disease that claims around 4,100 lives annually in the UK.